论文部分内容阅读
国家医药管理局科技考察团,应瑞典制药工业联合会(LIF)的邀请,自1982年12月4日到19日对瑞典制药工业进行了考察。在瑞典期间,代表团参观了 LIF 所属 Astra 公司的 L(?)kemedel 制药厂和 H(?)-ssle 制药研究公司,Kabivitrum 制药公司的营养输液厂和大豆油加工厂,Fortia 制药公司的 Phar-macia 生化制药厂,Uppsala 大学生物药学研究中心,H(?)ddinge 医院的新药临床药理部,瑞典国家卫生福利部的药品检定所等8个生产、临床和药政检验部门。在考察过程中我们感到,瑞方为中国代表团的到来,作了充分的准备,接待友好而热情,介绍简练而清楚,从日程安排中可以看出,瑞典朋友试图从制药研究到生产组织给中国科技考察团一个清楚的概念,而且有意地加大了制药研究的主要程序——药理和临
At the invitation of the Federation of Pharmaceutical Manufacturers of Sweden (LIF), the State Medical Administration delegation of science and technology conducted an inspection of the Swedish pharmaceutical industry from December 4 to December 19, During the visit to Sweden, the delegation visited the Astra L (?) Kemedel pharmaceutical factory and the H? Ssley pharmaceutical research company of LIF, the nutrition infusion plant and soybean oil processing plant of Kabivitrum Pharmaceutical Co., Phar- macia biochemical pharmaceutical factory, University of Uppsala biopharmaceutical research center, H (?) ddinge Hospital, Department of Clinical Pharmacology, the Swedish Ministry of Health and Welfare of the drug test 8 manufacturing, clinical and drug testing departments. During the inspection, we felt that Ruifang made full preparations for the arrival of the Chinese delegation. It is friendly and enthusiastic. The introduction is concise and clear. As can be seen from the schedule, Swedish friends tried to change from pharmaceutical research to production organization Chinese science and technology delegation a clear concept, but also deliberately increased the main pharmaceutical research program - Pharmacology and Pro